4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors

Details for Australian Patent Application No. 2010201167 (hide)

International Classifications

Event Publications

15 April 2010 Complete Application Filed

29 April 2010 Application Open to Public Inspection

Published as AU-B-2010201167

29 April 2010 Corrigenda

Complete Applications Filed - Name Index Under the name Allergan, Inc., Application No. 2010201167, under INID (54) correct the title to read 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors

31 May 2012 Application Accepted

Published as AU-B-2010201167

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.